Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Aptinyx Inc. (APTX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
2.1500-0.1300 (-5.70%)
At close: 04:00PM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Bollinger Bands

Bollinger Bands

Previous Close2.2800
Open2.2800
Bid2.1000 x 3200
Ask2.3400 x 3000
Day's Range2.1100 - 2.2800
52 Week Range2.1000 - 4.7300
Volume172,947
Avg. Volume159,980
Market Cap145.589M
Beta (5Y Monthly)1.31
PE Ratio (TTM)N/A
EPS (TTM)-1.0270
Earnings DateNov 09, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est9.00
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for APTX

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Aptinyx Inc.
    Daily – Vickers Top Buyers & Sellers for 12/02/2021The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
    Rating
    Fair Value
    Economic Moat
    3 days agoArgus Research
View more
  • Business Wire

    Aptinyx to Participate in Piper Sandler 33rd Annual Virtual Healthcare Conference

    EVANSTON, Ill., November 18, 2021--Aptinyx Inc. (Nasdaq: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous system disorders, today announced that company management will participate in a fireside chat at the Piper Sandler 33rd Annual Virtual Healthcare Conference being held November 29, 2021 through December 2, 2021.

  • Benzinga

    Notable Aptinyx Insider Makes $190K Buy

    Robert Hombach, Insider at Aptinyx (NASDAQ:APTX), made a large insider buy on November 12, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Friday showed that Hombach purchased 80,000 shares of Aptinyx at at a price of $2.40. The total transaction amounted to $192,000. Following the transaction, Hombach now owns 229,100 shares of Aptinyx, worth $556,713. Aptinyx shares are trading up 5.19% at $2.43 at the time of this writing on Tu

  • Motley Fool

    Aptinyx Inc. (APTX) Q3 2021 Earnings Call Transcript

    At this time, I would like to turn the call over to Patrick Flavin, senior manager, corporate development and investor relations at Aptinyx. Good afternoon, everyone, and thanks for joining us on today's conference call to discuss Aptinyx' financial and operating results for the third quarter of 2021.

Advertisement
Advertisement